The Paradigm Shift in Cardiovascular Screening
For decades, medical professionals have relied on indirect risk assessment to predict the likelihood of cardiovascular disease. By analyzing traditional markers such as blood pressure, cholesterol levels, and smoking habits, doctors have generated probabilistic scores for patients. However, a massive new international study, the REACT (Research on Atherosclerosis and Cardiovascular Risk) project, suggests that this approach may be fundamentally flawed. Instead of guessing a patient's risk, the study proposes a direct, imaging-based approach to identify the presence of atherosclerosis long before it manifests as a life-threatening heart attack or stroke.
The study, led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Rigshospitalet in Denmark, examined over 16,000 seemingly healthy individuals. The results were startling: 57.1% of the participants already exhibited signs of plaque buildup. By moving from a model of estimation to a model of direct detection, researchers believe they can pivot toward a precision medicine approach that allows for earlier, more effective clinical interventions.
Early Onset in Young Adults
Perhaps the most concerning discovery of the REACT study is the prevalence of plaque in the youngest age demographic. Among participants aged 18 to 29, approximately 1 in 13 individuals already showed signs of arterial disease. While this figure is lower than in older cohorts, its existence in apparently healthy young adults challenges the conventional belief that heart-related arterial plaque is purely a disease of middle or old age.
The prevalence of the disease tracks upward with age, hitting approximately 90% in participants between 60 and 70. By mapping these trends, the researchers have created one of the most comprehensive biological atlases of arterial health to date. These findings suggest that the disease develops quietly over decades, and by the time traditional screening methods flag a patient as 'high risk,' the structural damage to their arteries may have already been present for a significant portion of their adult life.
The Potential for Portable Ultrasound
A key logistical hurdle to widespread screening has always been the cost and complexity of advanced imaging. However, the study uncovered a critical diagnostic pattern: individuals with plaque in their coronary arteries almost invariably exhibited similar plaque in their carotid or femoral arteries. This correlation is a game-changer for diagnostics.
Because the carotid and femoral arteries are easily accessible via non-invasive, portable ultrasound devices, the researchers argue that these tools could become the gold standard for routine checkups. Unlike CT scans, which are expensive and radiation-intensive, a quick ultrasound could allow any trained healthcare provider to screen for silent atherosclerosis during a standard physical exam. If adopted, this strategy could significantly reduce the burden of cardiovascular disease by catching the illness at a stage where it might still be reversible through aggressive lifestyle changes or medication.
Why It Matters
- Beyond Risk Scores: Traditional metrics like cholesterol and blood pressure often miss patients who already have advanced plaque development.
- Early Detection: Identifying atherosclerosis in one's 20s or 30s provides a critical window for intervention that does not exist once severe damage has occurred.
- Scalable Solutions: The discovery that peripheral artery imaging acts as a proxy for heart health makes routine, low-cost screening highly feasible for primary care settings.
- Future Trials: The second phase of the REACT study (2027–2032) aims to confirm whether imaging-guided intervention directly prevents mortality compared to current clinical protocols.
